Rewarding effects of opiates are absent in mice lacking the receptor for substance P

Nature

Volumn 405, Issue 6783, 2000, Pages 180-183

  Murtra, Patricia ^a   Sheasby, Anne M ^b   Hunt, Stephen P ^b   De Felipe, Carmen ^a  

^a INSTITUTO DE NEUROCIENCIAS   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE DERIVATIVE; SUBSTANCE P; SUBSTANCE P RECEPTOR;

ANIMAL EXPERIMENT; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ABUSE; DRUG DEPENDENCE; GENE DISRUPTION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; COCAINE; CONDITIONING, CLASSICAL; CORPUS STRIATUM; CYCLIC AMP; FEMALE; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; MORPHINE DEPENDENCE; NARCOTICS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, NEUROKININ-1; RECEPTORS, OPIOID, MU; REWARD;

ANIMALIA;

EID: 0034636497     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35012069     Document Type: Article

References (28)

1. De Felipe, C. et al. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392, 394-397 (1998).
2. Kramer, M. S. et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281, 1640-1645 (1998).
3. Culman, J., Klee, S., Ohlendorf, C. & Unger, T. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioural responses to stress. J. Pharmacol. Exp. Ther. 280, 238-246 (1997).
4. Nakaya, Y. et al. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J. Comp. Neurol. 347, 249-274 (1994).
5. Wise, R. A. Neurobiology of addiction. Curr. Opin. Neurobiol. 6, 243-251 (1996).
6. Robbins, T. W. & Everitt, B. J. Drug addiction: bad habits add up. Nature 398, 567-570 (1999).
7. Koob, G. F., Sanna, P. P. & Bloom, F. E. Neuroscience of addiction. Neuron 21, 467-476 (1998).
8. Koob, G. K. & Le Moal, M. Drug abuse Hedonic homeostatic dysregulation. Science 278, 52-70 (1997).
9. Gerfen, C. R. Substance P (neurokinin-I) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res. 556, 165-170 (1991).
10. Maldonado, R. et al. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388, 586-589 (1995).
11. Baik, J. H. et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377, 424-428 (1995).
12. Wise, R. A. & Bozarth, M. A. A psychomotor stimulant theory of addiction. Psychol. Rev. 97, 469-492 (1987).
13. Bechara, A. & van der Kooy, D. A single brain stem substrate mediates the motivational effects of both opiates and food in nondeprived rats but not in deprived rats. Behav. Neurosci. 106, 351-363 (1992).
14. Maldonado, R., Girdlestone, D. & Roques, B. P. RP 67580, a selective antagonist of neurokinin-I receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats. Neurosci. Lett. 156, 135-140 (1993).
15. Matthes, H. W. D. et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the m-opioid-receptor gene. Nature 383, 819-823 (1996).
16. Rupniak, N. M. J. et al. A Pharmacological blockade or genetic deletion of substance P (NK1) receptors attenuates neonatal vocalisation in guinea-pigs and mice. Neuropharmacology (in the press).
17. Maldonado, R., Stimus, L., Gold, L. & Koob, G. F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261, 669-677 (1992).
18. Bozarth, M. A. Physical dependence produced by central morphine infusions: an anatomical mapping study. Neurosci. Biobehav. Rev. 18, 373-383 (1994).
19. Mansour, A., Fox, C. A., Burke, S., Akil, H. & Watson, S. J. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J. Chem. Neuroanat. 8, 283-305 (1995).
20. Kieffer, B. L., Beford, K., Gaveriaux-Ruff, C. & Hirth, C. G. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl Acad. Sci. USA 89, 12048-12052 (1992).
21. Izenwasser, S., Buzas, B. & Cox, B. M. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens. J. Pharmacol. Exp. Ther. 267, 145-152 (1993).
22. Nye, H. E. & Nestler, E. J. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49, 636-645 (1996).
23. Kelz, M. B. et al. Expression of the transcription factor delta FosB in the brain controls sensitivity to cocaine. Nature 401, 272-276 (1999).
24. Aubry, J. M., Schulz, M. F., Pagliusi, S., Schulz, P. & Kiss, J. Z. Coexpression of dopamine D2 and substance P (neurokinin-I) receptor messenger RNAs by a subpopulation of cholinergic neurons in the rat striatum. Neuroscience 53, 417-424 (1993).
25. Graybiel, A. M., Aosaki, T., Flaherty, A. W. & Kimura, M. The basal ganglia and adaptive motor control. Science 265, 1826-1831 (1994).
26. Elliott, P. J. & Iversen, S. D. Behavioural effects of tachykinins and related peptides. Brain Res. 381, 68-76 (1986).
27. Boix, F., Sandor, P., Nogueira, P. J., Huston, J. P. & Schwarting, R. K. Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region. Neuroscience 64, 1054-1055 (1995).
28. Shaham, Y. & Stewart, J. Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacol. 119, 334-341 (1995).